Top Stock Picks: Chevron, Pfizer & Amazon for Market Stability and Growth

Photo of author

By Maxwell Reed

Navigating today’s market requires a discerning eye, particularly with potential economic shifts on the horizon, such as those stemming from trade policies under the current administration of President Donald Trump. Investors are increasingly seeking strategies that offer stability and potential returns amidst this evolving landscape, leading analysts to highlight specific opportunities.

Seeking Stability in Volatile Times

Matt Maley, serving as the Chief Market Strategist at Miller Tabak, suggests that the market may not have reached its lowest point yet. In this environment, he advises considering specific equities that present defensive characteristics or unique growth narratives. His analysis points towards opportunities where investors can potentially find value even if broader market volatility persists.

Energy Sector Resilience: Chevron (CVX)

One area Maley highlights is the energy sector, specifically Chevron (CVX). Despite recent price declines which may have brought the stock near oversold levels, Maley sees it as a compelling option. He notes that the impact of OPEC decisions seems largely priced in, and he doesn’t anticipate a significant ramp-up in US drilling due to profitability constraints. Furthermore, potential geopolitical instability in the Middle East could provide support for energy prices.

Chevron offers investors a significant dividend yield, currently around 5%, coupled with a forward price-to-earnings (P/E) multiple near 13. Maley characterizes it as a stock that effectively “pays you while you wait” through market fluctuations, offering a blend of income and relative value.

Healthcare Value: Pfizer (PFE)

Another defensive consideration, according to Maley, is the pharmaceutical giant Pfizer (PFE). Its appeal lies in its valuation metrics, including a low P/E multiple around 7 and a substantial dividend yield approaching 8%. This suggests the stock might be undervalued, especially considering the ongoing success of its cardiovascular and oncology drug portfolios.

While potential regulatory shifts, including possible tariffs on pharmaceuticals discussed by the Trump administration, present a degree of uncertainty, the company’s fundamental strengths and robust pipeline could offer a buffer against market headwinds.

Long-Term Growth Perspective: Amazon (AMZN)

Shifting from purely defensive plays, Maley also addresses Amazon (AMZN), recommending a strategic approach despite potential pressures on consumer spending. He emphasizes that Amazon’s business extends far beyond retail, particularly highlighting its significant investments and potential in Artificial Intelligence (AI). Maley posits that Amazon’s return on investment in AI could surpass that of competitors like Microsoft.

Given this long-term potential, he suggests a strategy of gradual accumulation, advising investors to consider adding to their position incrementally throughout the remainder of the year. The goal is to build a position at an attractive average cost basis, betting on the company’s future growth trajectory, particularly driven by its advancements in AI.

Share